Staphylococcal toxic shock syndrome
Toxin-mediated · Dermatology
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Toxin-mediated multisystem illness from Staphylococcus aureus (tampons, wounds, packing, skin infection) with fever, diffuse macular erythroderma, hypotension and later desquamation.
Red flags
- Hypotension/shock
- Multi-organ dysfunction
- Rapid progression
- Diffuse erythroderma with fever
Assessment
Differential diagnosis
- Streptococcal toxic shock
- Septic shock
- Kawasaki disease
- Drug reaction (DRESS/SJS)
- Scarlet fever
Investigations
- FBC, U&E, LFTs, CK, coagulation, lactate
- Blood cultures and cultures of any focus
- Remove and culture any foreign material (tampon/packing)
- CRP and septic screen
Management
- Resuscitate aggressively for shock (fluids +/- vasopressors)
- Identify and remove the source (tampon, packing, debride infected wound)
- Start antibiotics including an antistaphylococcal agent plus a toxin-suppressing agent (clindamycin)
- Consider IV immunoglobulin in severe/refractory shock
- Supportive organ care in critical care
- Monitor for later desquamation and complications
Drugs & doses
Antistaphylococcal antibiotic (e.g. flucloxacillin, or vancomycin if MRSA) plus clindamycin
IV crystalloid resuscitation and vasopressors
IV immunoglobulin for severe cases
Source control (removal/debridement)
Disposition
Admit to ICU/HDU; involve microbiology.
Complications & pitfalls
- Multi-organ failure
- Death
- Desquamation and long-term sequelae
Exam pearls
- Source control is essential - remove tampons/packing
- Add clindamycin to suppress toxin production
- Desquamation of palms/soles occurs during recovery
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.